Caitlin McCracken
Research Subjects
Research Interests
Caitlin McCracken has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Dan Witmer2 shared publications
- Matthew J. Solomito
Research Department, Hartford HealthCare Bone and Joint Institute, Hartford, CT, USA
2 shared publications - Robert James Carangelo2 shared publications
- Sara Elaine Strecker
Bone and Joint Institute, Hartford Hospital, Hartford, Connecticut
2 shared publications - Andrea T. Kwaczala
Hartford Healthcare Bone and Joint Institute, Hartford, CT, USA
1 shared publication - Angie Alban1 shared publication
Latest Publications
- 9 September 2026
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
The Influence of Multiple Doses of Intravenous Tranexamic Acid on Transfusions and Complications in the Treatment of Fragility Hip Fractures
Objective: To determine the association between multiple intravenous tranexamic acid (TXA) doses and blood transfusions and complication rates in patient treated for fragility hip fractures. Design: Retrospective cohort study Setting: Single Level I trauma center Patients/Participants: Patients that were at least 50 years old and treated for a fragility fracture of the femoral neck (OTA31B), intertrochanteric (OTA31A1/A2), or subtrochanteric (OTA31A3) aspect of the femur between January 2018 and January 2024 were included . Intervention: TXA dosing (i.e. none, single dose, multiple doses) based on institutional protocols. TXA dosing was not based on intra-operative blood loss. Main Outcomes: The primary outcomes were post-operative blood transfusions, venous thromboembolism (VTE), surgical site infections (SSI), and death within one year of surgery compared among the study groups (patients that received no TXA, a single dose, or multiple doses). Results: A total of 1,691 patients (632 patients [average age 81.4 (53 to 104), 71.8% female] did not receive TXA, 551 [average age 79.9 (51 to 102), 72.4% female] received a single TXA dose, 508 [average age 79.2 (51 to 100), 70.3% female] received multiple TXA doses). Surgical time did not differ between groups (no TXA: 72.6 ± 30.9 minutes, single dose: 74.9 ±32.9 minutes, and multiple doses: 70.6 ± 32.3 minutes, p=0.073). TXA use significantly reduced the risk of blood transfusion compared to the no TXA group (no TXA: 31.8%, single dose: 15.9%, multidose 14.2%, p<0.001). There were no significant differences in transfusion rates with two, three and four doses of TXA compared to the single dose group (single dose: 15.9%, two doses: 15.3% three doses 13.6% and four doses 13.1%, p=0.791). The frequency of VTE was the lowest in the single dose group compared to the other study groups (no TXA: 2.7%, single dose: 0.9%, multiple dose 2.7%, p=0.040). There was no difference in death rates among study groups (no TXA: 9.3%, single dose: 7.3%, multiple dose 8.5%, p=0.433). Conclusion: Intravenous tranexamic acid (TXA) reduced transfusion needs without an increased complication rate in comparison to not using TXA. Regression analysis demonstrated that three and four doses of TXA did significantly reduce the transfusion rate beyond a single dose of TXA, but did not provide significant reduction beyond two-doses. Level of Evidence: Level 3
- 9 September 2026
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
The Influence of Multiple Doses of Intravenous Tranexamic Acid on Transfusions and Complications in the Treatment of Fragility Hip Fractures
Objective: To determine the association between multiple intravenous tranexamic acid (TXA) doses and blood transfusions and complication rates in patient treated for fragility hip fractures. Design: Retrospective cohort study Setting: Single Level I trauma center Patients/Participants: Patients that were at least 50 years old and treated for a fragility fracture of the femoral neck (OTA31B), intertrochanteric (OTA31A1/A2), or subtrochanteric (OTA31A3) aspect of the femur between January 2018 and January 2024 were included . Intervention: TXA dosing (i.e. none, single dose, multiple doses) based on institutional protocols. TXA dosing was not based on intra-operative blood loss. Main Outcomes: The primary outcomes were post-operative blood transfusions, venous thromboembolism (VTE), surgical site infections (SSI), and death within one year of surgery compared among the study groups (patients that received no TXA, a single dose, or multiple doses). Results: A total of 1,691 patients (632 patients [average age 81.4 (53 to 104), 71.8% female] did not receive TXA, 551 [average age 79.9 (51 to 102), 72.4% female] received a single TXA dose, 508 [average age 79.2 (51 to 100), 70.3% female] received multiple TXA doses). Surgical time did not differ between groups (no TXA: 72.6 ± 30.9 minutes, single dose: 74.9 ±32.9 minutes, and multiple doses: 70.6 ± 32.3 minutes, p=0.073). TXA use significantly reduced the risk of blood transfusion compared to the no TXA group (no TXA: 31.8%, single dose: 15.9%, multidose 14.2%, p<0.001). There were no significant differences in transfusion rates with two, three and four doses of TXA compared to the single dose group (single dose: 15.9%, two doses: 15.3% three doses 13.6% and four doses 13.1%, p=0.791). The frequency of VTE was the lowest in the single dose group compared to the other study groups (no TXA: 2.7%, single dose: 0.9%, multiple dose 2.7%, p=0.040). There was no difference in death rates among study groups (no TXA: 9.3%, single dose: 7.3%, multiple dose 8.5%, p=0.433). Conclusion: Intravenous tranexamic acid (TXA) reduced transfusion needs without an increased complication rate in comparison to not using TXA. Regression analysis demonstrated that three and four doses of TXA did significantly reduce the transfusion rate beyond a single dose of TXA, but did not provide significant reduction beyond two-doses. Level of Evidence: Level 3
- Open Access
- 1 August 2026
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 10 (8)
Implementation of Robotic-Assisted Procedure for Total Hip Arthroplasty Is Not Economical in a High-Volume Orthopaedic Facility
Background: Advances in elective primary total hip arthroplasty (THA) have led to the use of robotic assistance and computer navigation during surgery; recent reports have demonstrated substantial benefits of this technology. However, few studies have made a head-to-head comparison of technology with a specific focus on patient-reported outcomes (PROs) when preoperative patient profiles are well controlled. Therefore, the purpose of this study was to compare outcomes among patients who underwent conventional, robotic-assisted, and computer-navigated procedures. Methods: This retrospective study included patients aged 25 to 89 years who underwent THAs between January 2020 and May 2025. Patients were matched on age, body mass index (BMI), Charlson Comorbidity Index (CCI), and preoperative Hip Disability and Osteoarthritis Outcome Score for Joint Replacement and were assigned to study groups based on the technology used: (1) conventional, (2) robotic-assisted, and (3) computer-navigated. Postoperative recovery metrics between groups were compared up to 1 year from the surgery. Results: A total of 3799 patients were included: 2582 (68%) in the conventional group, 389 (10%) in the robotic-assisted group, and 828 (22%) in the computer-navigated group. PROs improved with no differences between groups by 12 months but showed slightly slower recovery in computer-navigated cases. Complication rates (return to operating room and hospital readmittance) were similar in all groups. Both robotic-assisted surgery and computer-navigated procedures cost around $1000 more than the conventional procedure, with robotic-assisted procedures taking 3 minutes longer than conventional procedures ( P < 0.05). Conclusion: Despite added cost, the technology-assisted procedures did not offer substantial improvements to surgical outcomes when used in primary THAs in a high-volume orthopaedic hospital. When controlled by matching demographics, comorbidities, and PROs, the technology-supported THA patients had no clinically relevant differences in postoperative outcomes and had higher hospital utilization compared with the conventional group.
- 1 August 2026
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 10 (8)
Open AccessImplementation of Robotic-Assisted Procedure for Total Hip Arthroplasty Is Not Economical in a High-Volume Orthopaedic Facility
Background: Advances in elective primary total hip arthroplasty (THA) have led to the use of robotic assistance and computer navigation during surgery; recent reports have demonstrated substantial benefits of this technology. However, few studies have made a head-to-head comparison of technology with a specific focus on patient-reported outcomes (PROs) when preoperative patient profiles are well controlled. Therefore, the purpose of this study was to compare outcomes among patients who underwent conventional, robotic-assisted, and computer-navigated procedures. Methods: This retrospective study included patients aged 25 to 89 years who underwent THAs between January 2020 and May 2025. Patients were matched on age, body mass index (BMI), Charlson Comorbidity Index (CCI), and preoperative Hip Disability and Osteoarthritis Outcome Score for Joint Replacement and were assigned to study groups based on the technology used: (1) conventional, (2) robotic-assisted, and (3) computer-navigated. Postoperative recovery metrics between groups were compared up to 1 year from the surgery. Results: A total of 3799 patients were included: 2582 (68%) in the conventional group, 389 (10%) in the robotic-assisted group, and 828 (22%) in the computer-navigated group. PROs improved with no differences between groups by 12 months but showed slightly slower recovery in computer-navigated cases. Complication rates (return to operating room and hospital readmittance) were similar in all groups. Both robotic-assisted surgery and computer-navigated procedures cost around $1000 more than the conventional procedure, with robotic-assisted procedures taking 3 minutes longer than conventional procedures ( P < 0.05). Conclusion: Despite added cost, the technology-assisted procedures did not offer substantial improvements to surgical outcomes when used in primary THAs in a high-volume orthopaedic hospital. When controlled by matching demographics, comorbidities, and PROs, the technology-supported THA patients had no clinically relevant differences in postoperative outcomes and had higher hospital utilization compared with the conventional group.
- Open Access
- 1 May 2025
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 9 (5)
The Effect of the Design of Polyethylene Inserts in Total Knee Arthroplasty on Patient Reported Outcomes
Introduction: Several types of polyethylene liners have been developed to address the specific needs of patients' anatomy within total knee arthroplasty (TKA). In modern TKA, the posterior-stabilized (PS) and the cruciate-retaining (CR) designs are the most common, with the medial congruent (MC) design becoming more popular. The MC total knee arthroplasty has a posterior dwell point allowing for more flexion. The purpose of this study was to determine differences in patient-reported outcomes (PROMs) or postoperative outcomes between these three TKAs. Methods: Patients who underwent a primary, elective, unilateral TKA between June 2021 and July 2023 were identified. Demographics and perioperative and postoperative outcomes were extracted from the medical record. PROMs from 624 patients were obtained through a digital engagement platform. A P value ≤0.05 was considered statistically significant. Results: Patients were subdivided into three groups; 111 PS-TKA, 278 CR-TKA, and 235 MC-TKAs. Most implants were Zimmer (71.5%) and were cemented (92.9%). Patients in the CR group were predominantly male (P = 0.003) and had a lower body mass index (P < 0.001). No differences were seen in Knee Injury and Osteoarthritis Outcome Score for Joint Replacement scores at any time point (preoperative: P = 0.073; 12 weeks: P = 0.144; 6 months: P = 0.666; 1 year: P = 0.622). A similar percentage of patients met the minimal clinically important difference (P = 0.480), and Forgotten Joint Scores were equivalent (P = 0.930). Patient physical therapy parameters (Timed Up and Go test [P = 0.779] and ambulation distance [P = 0.103]), inpatient pain levels (at rest: P = 0.101, with activity: P = 0.052), or morphine milligram equivalents dosed (P = 0.608) were comparable. No differences were seen in 30-day complications. Conclusion: This study fails to demonstrate a difference in PROMs, functional parameters, or complications between the PS-TKAs, CR-TKAs, and MC-TKAs. All three constructs perform similarly in the immediate postoperative period. Because equivalent outcomes occur with each polyethylene, implant choice should be left to physician preference.
- 1 May 2025
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 9 (5)
Open AccessThe Effect of the Design of Polyethylene Inserts in Total Knee Arthroplasty on Patient Reported Outcomes
Introduction: Several types of polyethylene liners have been developed to address the specific needs of patients' anatomy within total knee arthroplasty (TKA). In modern TKA, the posterior-stabilized (PS) and the cruciate-retaining (CR) designs are the most common, with the medial congruent (MC) design becoming more popular. The MC total knee arthroplasty has a posterior dwell point allowing for more flexion. The purpose of this study was to determine differences in patient-reported outcomes (PROMs) or postoperative outcomes between these three TKAs. Methods: Patients who underwent a primary, elective, unilateral TKA between June 2021 and July 2023 were identified. Demographics and perioperative and postoperative outcomes were extracted from the medical record. PROMs from 624 patients were obtained through a digital engagement platform. A P value ≤0.05 was considered statistically significant. Results: Patients were subdivided into three groups; 111 PS-TKA, 278 CR-TKA, and 235 MC-TKAs. Most implants were Zimmer (71.5%) and were cemented (92.9%). Patients in the CR group were predominantly male (P = 0.003) and had a lower body mass index (P < 0.001). No differences were seen in Knee Injury and Osteoarthritis Outcome Score for Joint Replacement scores at any time point (preoperative: P = 0.073; 12 weeks: P = 0.144; 6 months: P = 0.666; 1 year: P = 0.622). A similar percentage of patients met the minimal clinically important difference (P = 0.480), and Forgotten Joint Scores were equivalent (P = 0.930). Patient physical therapy parameters (Timed Up and Go test [P = 0.779] and ambulation distance [P = 0.103]), inpatient pain levels (at rest: P = 0.101, with activity: P = 0.052), or morphine milligram equivalents dosed (P = 0.608) were comparable. No differences were seen in 30-day complications. Conclusion: This study fails to demonstrate a difference in PROMs, functional parameters, or complications between the PS-TKAs, CR-TKAs, and MC-TKAs. All three constructs perform similarly in the immediate postoperative period. Because equivalent outcomes occur with each polyethylene, implant choice should be left to physician preference.